Fig. 4From: Targeting FBPase is an emerging novel approach for cancer therapyStructures of chemical inhibitors restoring FBPase. a 5-Aza-deoxycytidin (5AZA) [117], b BAY11-7085 [118], c bortezomib [119], d dexamethasone [120], e LBH589 [121], f SAHA [122], g sodium butyrate (NaBu) [123], h tranylcypromine (TCP) [124], i trichostatin A (TSA) [125]Back to article page